深耕中医药领域聚力多点突破 精华制药董事长获评“科创江苏”企业创新达人

Group 1 - The "Innovation Leaders" list for 2025 in Jiangsu has been released, featuring 100 innovators from various industries, including Yin Hongyu, Chairman of Jinghua Pharmaceutical [1][3] - The award aims to discover, cultivate, and promote outstanding technological talents in enterprises, focusing on entrepreneurs, skilled researchers, and craftsmen to enhance innovation vitality in the province [3] - Jinghua Pharmaceutical is committed to innovation, with successful product developments and expansions planned for 2025, achieving significant results [3] Group 2 - Jinghua Pharmaceutical's Wang's Baochi Pill has been successfully registered and listed in Macau, marking it as the first traditional Chinese medicine heritage product to "go global" [3] - The company has made advancements in product research, with the Jide Sheng Snake Medicine Tablet showing significant efficacy for shingles symptoms and being included in expert consensus guidelines [3] - The company has integrated ESG principles into its strategic operations, achieving high standards in compliance and receiving the "2025 Annual ESG Value Transmission Award" for its contributions to sustainable development [4] Group 3 - Looking ahead to the 14th Five-Year Plan, Jinghua Pharmaceutical aims to strengthen its dual focus on traditional Chinese medicine and raw materials while entering the health industry, creating a new development model with collaborative efforts [4]